Skip to main content
Premium Trial:

Request an Annual Quote

Swift Biosciences ACE2 Swift Normalase Amplicon Panel

Swift Biosciences has launched the ACE2 Swift Normalase Amplicon Panel, a next-generation sequencing library preparation assay for use in research on COVID-19.

ACE2 is the key receptor for entry of the SARS-CoV-2 virus into human cells.

The Swift panel uses single-tube multiplex PCR and offers 100 percent coverage of coding sequences. It can generate libraries from low input quantities of DNA and libraries can be quantified or normalized using Normalase reagents.

Data analysis and interpretation are available through Swift's VarSome platform.

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.